BACKGROUND: Abnormalities have been identified in the Cognitive Control Network (CCN) and the Default Mode Network (DMN) during episodes of late-life depression. This study examined whether functional connectivity at rest (FC) within these networks characterizes late-life depression and predicts antidepressant response. METHODS: 26 non-demented, non-MCI older adults were studied. Of these, 16 had major depression and 10 had no psychopathology. Depressed patients were treated with escitalopram (target dose 20 mg) for 12 weeks after a 2-week placebo phase. Resting state time series was determined prior to treatment. FC within the CCN was determined by placing seeds in the dACC and the DLPFC bilaterally. FC within the DMN was assessed from a seed placed in the posterior cingulate. RESULTS: Low resting FC within the CCN and high resting FC within the DMN distinguished depressed from normal elderly subjects. Beyond this "double dissociation", low resting FC within the CCN predicted low remission rate and persistence of depressive symptoms and signs, apathy, and dysexecutive behavior after treatment with escitalopram. In contrast, resting FC within the DMN was correlated with pessimism but did not predict treatment response. CONCLUSIONS: If confirmed, these findings may serve as a signature of the brain's functional topography characterizing late-life depression and sustaining its symptoms. By identifying the network abnormalities underlying biologically meaningful characteristics (apathy, dysexecutive behavior, pessimism) and sustaining late-life depression, these findings can provide a novel target on which new somatic and psychosocial treatments can be tested. Published by Elsevier B.V.
BACKGROUND: Abnormalities have been identified in the Cognitive Control Network (CCN) and the Default Mode Network (DMN) during episodes of late-life depression. This study examined whether functional connectivity at rest (FC) within these networks characterizes late-life depression and predicts antidepressant response. METHODS: 26 non-demented, non-MCI older adults were studied. Of these, 16 had major depression and 10 had no psychopathology. Depressedpatients were treated with escitalopram (target dose 20 mg) for 12 weeks after a 2-week placebo phase. Resting state time series was determined prior to treatment. FC within the CCN was determined by placing seeds in the dACC and the DLPFC bilaterally. FC within the DMN was assessed from a seed placed in the posterior cingulate. RESULTS: Low resting FC within the CCN and high resting FC within the DMN distinguished depressed from normal elderly subjects. Beyond this "double dissociation", low resting FC within the CCN predicted low remission rate and persistence of depressive symptoms and signs, apathy, and dysexecutive behavior after treatment with escitalopram. In contrast, resting FC within the DMN was correlated with pessimism but did not predict treatment response. CONCLUSIONS: If confirmed, these findings may serve as a signature of the brain's functional topography characterizing late-life depression and sustaining its symptoms. By identifying the network abnormalities underlying biologically meaningful characteristics (apathy, dysexecutive behavior, pessimism) and sustaining late-life depression, these findings can provide a novel target on which new somatic and psychosocial treatments can be tested. Published by Elsevier B.V.
Authors: Silvina G Horovitz; Masaki Fukunaga; Jacco A de Zwart; Peter van Gelderen; Susan C Fulton; Thomas J Balkin; Jeff H Duyn Journal: Hum Brain Mapp Date: 2008-06 Impact factor: 5.038
Authors: Yvette I Sheline; Deanna M Barch; Joseph L Price; Melissa M Rundle; S Neil Vaishnavi; Abraham Z Snyder; Mark A Mintun; Suzhi Wang; Rebecca S Coalson; Marcus E Raichle Journal: Proc Natl Acad Sci U S A Date: 2009-01-26 Impact factor: 11.205
Authors: Yvette I Sheline; Joseph L Price; S Neil Vaishnavi; Mark A Mintun; Deanna M Barch; Adrian A Epstein; Consuelo H Wilkins; Abraham Z Snyder; Lars Couture; Kenneth Schechtman; Robert C McKinstry Journal: Am J Psychiatry Date: 2008-02-15 Impact factor: 18.112
Authors: George S Alexopoulos; Christopher F Murphy; Faith M Gunning-Dixon; Vassilios Latoussakis; Dora Kanellopoulos; Sibel Klimstra; Kelvin O Lim; Matthew J Hoptman Journal: Am J Psychiatry Date: 2008-01-02 Impact factor: 18.112
Authors: Faith M Gunning-Dixon; Matthew J Hoptman; Kelvin O Lim; Christopher F Murphy; Sibel Klimstra; Vassilios Latoussakis; Magdalena Majcher-Tascio; Jan Hrabe; Babak A Ardekani; George S Alexopoulos Journal: Am J Geriatr Psychiatry Date: 2008-04 Impact factor: 4.105
Authors: Christina L Fales; Deanna M Barch; Melissa M Rundle; Mark A Mintun; Jose Mathews; Abraham Z Snyder; Yvette I Sheline Journal: J Affect Disord Date: 2008-06-17 Impact factor: 4.839
Authors: Howard J Aizenstein; Meryl A Butters; Minjie Wu; Laura M Mazurkewicz; V Andrew Stenger; Peter J Gianaros; James T Becker; Charles F Reynolds; Cameron S Carter Journal: Am J Geriatr Psychiatry Date: 2009-01 Impact factor: 4.105
Authors: Warren D Taylor; Maragatha Kuchibhatla; Martha E Payne; James R Macfall; Yvette I Sheline; K Ranga Krishnan; P Murali Doraiswamy Journal: PLoS One Date: 2008-09-24 Impact factor: 3.240
Authors: Wenjun Li; B Douglas Ward; Chunming Xie; Jennifer L Jones; Piero G Antuono; Shi-Jiang Li; Joseph S Goveas Journal: J Psychiatr Res Date: 2015-09-09 Impact factor: 4.791
Authors: Jason A Gandelman; Kimberly Albert; Brian D Boyd; Jung Woo Park; Meghan Riddle; Neil D Woodward; Hakmook Kang; Bennett A Landman; Warren D Taylor Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2018-09-21
Authors: Howard J Aizenstein; Alexander Khalaf; Sarah E Walker; Carmen Andreescu Journal: J Geriatr Psychiatry Neurol Date: 2013-12-30 Impact factor: 2.680
Authors: Jeffrey M Spielberg; Gregory A Miller; Stacie L Warren; Bradley P Sutton; Marie Banich; Wendy Heller Journal: Depress Anxiety Date: 2014-04-17 Impact factor: 6.505
Authors: Wenjun Li; B Douglas Ward; Xiaolin Liu; Gang Chen; Jennifer L Jones; Piero G Antuono; Shi-Jiang Li; Joseph S Goveas Journal: J Neurol Neurosurg Psychiatry Date: 2014-11-28 Impact factor: 10.154
Authors: Sarah Shizuko Morimoto; Dora Kanellopoulos; Kevin J Manning; George S Alexopoulos Journal: Ann N Y Acad Sci Date: 2015-02-05 Impact factor: 5.691
Authors: Wenjun Li; Yang Wang; B Douglas Ward; Piero G Antuono; Shi-Jiang Li; Joseph S Goveas Journal: J Psychiatr Res Date: 2016-12-12 Impact factor: 4.791